ELV 10-Q Quarterly Report Sept. 30, 2025 | Alphaminr
Elevance Health, Inc.
Screener Snapshot View

ELV 10-Q Quarter
ended Sept. 30, 2025


Finance Dashboard
Elevance Health, Inc. - ELV
$330.75
-2.74 (-0.82%)
Market Cap
$73,505,470,862
Enterprise Value
$27,679,470,862
Average Volume
$1,769,876

Valuation & Solvency

P/Tangible Book
1.70
P/E
13.50
P/S
0.38
EV/EBITDA
2.76
EV/Sales
0.14
EV/FCF
7.35
Dividend Yield
2.07%
Payout Ratio
27.56%
Total Debt
$929,000,000
Cash & Marketable Securities
$34,996,000,000
Quick Ratio
1.56
Debt/Equity
0.02
Net Debt/EBITDA
-
Interest Coverage Ratio
5.42

About

Industry
Medical - Healthcare Plans
Exchange
NYSE
Country
US
Beta
0.53

Company Description

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.